Connect with us

News

Google’s New AI Technology May Revolutionize Cancer Treatment

The AI model, called AlphaProteo, can design targeted protein binders, promising breakthroughs in cancer treatments and diseases like diabetes.

Published

on

google's new ai technology may revolutionize cancer treatment
Google DeepMind

Proteins are integral to many biological processes within the human body. They play a crucial role in our immune system, helping us to fend off diseases and maintain overall health.

Until now, developing protein molecules for medical purposes has been a time-consuming, expensive, and complex process. However, advancements in artificial intelligence have significantly improved the process, making it more efficient and accessible.

Recently, Google DeepMind researchers introduced a cutting-edge AI-powered model that can create protein binders targeting specific proteins. The groundbreaking development allows scientists to design custom protein molecules that specifically target only cancerous cells while minimizing harm to healthy ones. Hopefully, this will lead to more effective and less harmful treatments for cancer patients.

The newly developed AI model, known as AlphaProteo, also promises to be a game-changer in the diagnosis and treatment of various diseases, including autoimmune disorders like rheumatoid arthritis, and chronic illnesses such as diabetes.

This isn’t Google DeepMind’s first foray into using AI for protein research. In 2021, the company launched AlphaFold, another AI-powered system aimed at predicting the structure of proteins. AlphaProteo builds upon this foundation, further advancing AI’s role in medical research.

Also Read: Tumor-Fighting Nanobots Could Revolutionize Cancer Treatment

The system’s training involved large datasets from the Protein Data Bank and insights from Google’s previous AI research. By leveraging this wealth of data, AlphaProteo avoids the need for traditional, resource-intensive testing methods, saving both time and money.

One of the most significant achievements during AlphaProteo’s testing phase was the strength of the protein binders it produced. On average, these binders were ten times more effective than current designs. The research also included testing protein binders for various target molecules, including those related to diseases like COVID-19 and leukemia.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 23K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Microsoft Plans $10 Billion-Plus Gulf Expansion Despite Iran Conflict

Security is shaping Microsoft’s approach, from resilience work with governments to what it will say about how the money splits by country.

Published

on

microsoft plans $10 billion plus gulf expansion despite iran conflict
Microsoft

Microsoft is planning more than $10 billion of investment across the UAE, Saudi Arabia, Qatar and Kuwait through 2030, Vice Chair and President Brad Smith told Reuters, calling the spending schedule aggressive. The Iranian conflict that began on February 28 has not persuaded the company to scale back.

“We’re sustaining all the investments we planned to make before this conflict started, and we are in fact adding to them,” Smith said. The $10 billion-plus total does not, however, show how large those additions are.

The investment, which Smith described as part of Microsoft’s continued infrastructure expansion, is aimed at cloud and AI infrastructure and at the company’s growing regional operations. Microsoft also intends to put more than $400 million into subsea and terrestrial connectivity across the Middle East by 2030.

The spending fits the region’s own ambitions too. Gulf governments have been investing heavily in AI infrastructure as part of a push to diversify their economies beyond oil and gas and turn themselves into global technology hubs. Major cloud and AI providers have been drawn in part by the land and relatively low-cost energy on offer.

Microsoft is widening its partnerships with regional AI companies, though not on identical terms. In 2024, it invested $1.5 billion in Abu Dhabi-based G42 for a minority stake, and Smith currently sits on G42’s board. Saudi Arabia’s Humain and Qatar’s Qai are working with Microsoft on selected priority areas, but Smith said the company does not plan to make capital investments in either.

Also Read: Egypt’s Mobile Wallets Are Booming, But Cash Still Has Power

The conflict has added another strand to Microsoft’s work in the region. Since it began, Smith said, the company has supported regional partners with digital resilience assessments, and it is now working with Gulf countries through a digital resilience initiative focused on preparedness and the protection of critical data.

So far, the company has given no country-by-country breakdown of the investment, citing security among other factors. So while the headline figure is public, how Microsoft divides the spending among the four countries is not.

Continue Reading

#Trending